Champix (Varenicline) – Comprehensive Patient Information for Australian Users
Basic Product Information
| International Non-Proprietary Name (INN) | Varenicline |
| Australian Brand Names | Champix (most common), generic varenicline (availability varies) |
| ATC Code | N07BA03 |
| Available Forms & Strengths | Tablets: 0.5 mg, 1 mg |
| Manufacturers | Pfizer Australia Pty Ltd and approved generic manufacturers |
| Prescription Status | Prescription Only Medicine (Schedule 4, S4) |
Mechanism of Action
For Patients: Champix works by reducing both the urge to smoke and the pleasurable effects of nicotine. It acts on the same brain receptors that nicotine does, but in a way that eases cravings and withdrawal while also making smoking less satisfying.
For Healthcare Professionals: Varenicline is a partial agonist of the alpha4-beta2 neuronal nicotinic acetylcholine receptor. It provides moderate stimulation to reduce withdrawal while blocking the rewarding effects of smoked nicotine (competitive inhibition), facilitating smoking cessation.
Pharmacokinetics
- Absorption: Rapidly absorbed orally; peak plasma concentrations within 3–4 hours.
- Bioavailability: ~90%, independent of food intake.
- Distribution: Minimal protein binding; widely distributed in body tissues.
- Metabolism: Minimally metabolised; mainly excreted unchanged in urine.
- Elimination Half-life: Approximately 24 hours.
- Clearance: By renal filtration and active tubular secretion.
Use in Everyday Life and Best Practices
- Typical Course: 12-week daily treatment is standard, extendable to 24 weeks for extra support.
- Start Date: Begin 1–2 weeks before your designated 'quit date'. Your doctor will help set this up.
- Missed Dose: If you forget a dose, take it when you remember. If close to the next dose, skip and resume as normal (do not double up).
- Support: Combining Champix with quitting support such as Quitline 13 7848 or local smoking cessation programmes increases success chances.
- Driving & Operating Machinery: Take caution until you know how Champix affects you, as it can cause dizziness or drowsiness in some people.
Dosing in the Morning vs Evening
- Doses can be taken morning or evening.
- Commonly recommended in the morning to reduce the risk of insomnia at night.
- If stomach upset occurs, taking Champix with food or water in the day may help.
- Important to take doses at the same time daily for steady therapeutic levels and best outcomes.
Taking with Food or on an Empty Stomach
- Champix can be taken with or without food.
- Taking with food or a glass of water may reduce risks of feeling sick (nausea), the most common side effect.
- Australian dietary habits (breakfast, lunch, dinner) offer convenient opportunities to align dosing with meals if preferred.
- Alcohol has not been directly shown to interfere, though moderation is always best, especially in the early phase of therapy.
Interaction Warnings
| Type | Interaction/Advice |
| Food | No clinically significant interaction, but may reduce stomach upset if taken with food or water. |
| Alcohol | Caution, as some patients may experience increased intoxication or mood changes. |
| Other Medicines | - NRT (nicotine replacement therapy): Not to be used together with Champix unless advised by your doctor.
- CNS-acting drugs: Monitor for enhanced neuropsychiatric side effects with antidepressants, antipsychotics, or benzodiazepines.
- Warfarin: Stop smoking may change blood levels of warfarin — INR may need monitoring.
- Insulin/Theophylline: Smoking cessation may alter metabolism and dosing requirements—check with your doctor.
|
Indications
| Indication | Status in Australia |
| Smoking Cessation (Adults) | Approved (TGA registered) |
| Smoking reduction/quit attempts in at-risk groups (e.g. those with CV disease, respiratory illness) | Supported in guidelines; off-label use by clinical discretion |
| Other Tobacco Use Disorders | Off-label, limited evidence |
Dosing According to Clinical Indication
| Population | Initial Dosing (Days 1–3) | Titration Phase (Days 4–7) | Usual Maintenance Dose (Weeks 2–12) |
| Adult | 0.5 mg once daily | 0.5 mg twice daily | 1 mg twice daily |
| Elderly (≥65) | As adult; monitor renal function for dose adjustment | As adult | As adult unless renal impairment |
| Pediatric (<18) | Not recommended (safety not established) |
| Renal Impairment | Dose reduction advised; consult specialist |
Safety Profile and Side Effects
| Frequency | Potential Side Effects |
| Very Common (>1/10) | Nausea (30%), headache, insomnia, abnormal dreams |
| Common (>1/100 to <1/10) | Dizziness, drowsiness, irritability, increased appetite, weight gain, dry mouth, constipation, flatulence, vomiting |
| Uncommon (>1/1,000 to <1/100) | Agitation, mood changes, depression, anxiety, chest pain, increased heart rate |
| Rare (<1/1,000) | Seizures, allergic reactions, cardiovascular events (especially in those with pre-existing disease) |
| Warnings | Risk of neuropsychiatric symptoms (rare: suicidal thoughts, severe mood changes). Contact your doctor if you experience mood disturbance or behaviour change. Caution in those with mental health history. |
Guidelines for Proper Use in Australia
- Set a firm quit date before starting treatment; begin dosing 1–2 weeks prior.
- Inform your pharmacist or GP of all other medications—include over-the-counter and herbal supplements.
- Always swallow tablets whole with a full glass of water. Do not split or crush tablets.
- If kidney problems are present or develop, report these for possible dose adjustment.
- If you develop new or worsening mood symptoms, unusual thoughts, or sleep problems, seek help from your prescriber.
- Regular follow-up visits with your GP or quitting counsellor can increase your chance of quitting successfully.
- Dispose of unused tablets properly—consult your pharmacist for return/disposal through medicines return schemes.
Alternative Treatment Options
- Nicotine Replacement Therapy (NRT): Patches, gums, lozenges, inhalers. Available over-the-counter and PBS-subsidised. Generally safe and well-tolerated, but may be less effective than Champix in some patients.
- Bupropion (Zyban): Prescription-only, PBS-listed for eligible patients. Slightly lower quit rates compared to Champix, may suit those unable to use NRT or varenicline.
- Non-pharmacological: Counselling, support groups (eg, Quitline 13 7848), smartphone apps.
- Comparison overview: Champix generally shows higher abstinence rates but greater risk of neuropsychiatric side effects compared to NRT/bupropion. Choose based on medical history, preference, tolerability, and GP advice.
Legal, Registration, and Reimbursement Status in Australia
- TGA Registration: Approved by Therapeutic Goods Administration (TGA).
- PBS Reimbursement: Listed on the Pharmaceutical Benefits Scheme (PBS) for eligible patients—subsidised for standard 12-week course, with repeat courses possible by strict criteria (visit PBS for eligibility).
- Legal Status: Schedule 4 (Prescription Only).
- Supply & Pharmacist Role: Only available via prescription from a registered doctor, dispensed by community pharmacies across Australia.
- Medicine Returns: Unused/unneeded tablets should be returned to a pharmacy for safe disposal.
Latest Research and Clinical Guidance (2022–2025)
- Cochrane Review (2023): Confirms varenicline is the most effective single therapy for smoking cessation in adults in the general population; abstinence rates are highest when combined with behaviour support.
- TGA Safety Updates (2022–2024): No new major safety alerts, but ongoing monitoring for neuropsychiatric effects—prompt reporting of symptoms is recommended.
- Australian RACGP Guidelines (2024): Varenicline remains first-line for most adults, except during pregnancy (RACGP).
- Other Evidence: Emerging data suggests varenicline may suit adults with cardiovascular or respiratory disease, but clinical assessment and monitoring is advised (Thorax journal, 2023).
Availability and Delivery
| Pack Size | Tablet Strength | Indicative Price* | Availability |
| Starter Pack (11+14 tablets) | 0.5 mg & 1 mg | $130–$180 (PBS co-payment lower for eligible patients) | Most community and online pharmacies in major cities |
| Continuing Pack (56 tablets) | 1 mg | $100–$150 | Widely available; advance order for rural/remote |
*Prices indicative, may vary by location and PBS status | City | Typical Delivery Time (Online Pharmacy) |
| Sydney | 1–2 business days |
| Melbourne | 1–3 business days |
| Brisbane | 2–3 business days |
| Perth | 3–5 business days |
| Hobart/Darwin/Adelaide | 2–4 business days |
| Rural/Remote | Allow 4–7 business days |
Frequently Asked Questions (FAQ)
- Q1: What if I experience severe mood changes or suicidal thoughts while taking Champix?
A: Stop taking the medication immediately and seek urgent medical advice from your GP or nearest emergency department. Mood changes are rare but serious and must be reported. - Q2: Can I combine Champix with nicotine replacement (patches/gum)?
A: Generally no, except if your doctor specifically recommends it. Combined use increases side effect risk and is not standard practice in Australia. - Q3: How soon after stopping smoking will I notice benefits?
A: Some health improvements may appear within days (better breathing, taste, and smell); other benefits like reduced risk of disease become more noticeable over weeks to months. Varenicline simply increases your quit success odds compared with going “cold turkey”. - Q4: Is Champix safe in pregnancy or breastfeeding?
A: Champix is not recommended in pregnancy or while breastfeeding due to insufficient safety data. Speak with your doctor about the safest alternative strategies. - Q5: Can I get a repeat course if I relapse?
A: Under PBS rules, repeat courses may be subsidised if you continue to smoke and meet criteria, but only after a washout period—consult your doctor for individual guidance.
If you have further questions about Champix (varenicline), your doctor, pharmacist, or Quitline (13 7848) can provide trusted personalised advice. This information is designed to supplement, not replace, the advice of your healthcare professionals.
